The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
Open accessAbstract
In the present study we demonstrate that human monocytes activated by lipopolysaccharides (LPS) were able to produce high levels of interleukin 10 (IL-10), previously designated cytokine synthesis inhibitory factor (CSIF), in a dose dependent fashion. IL-10 was detectable 7 h after activation of the monocytes and maximal levels of IL-10 production were observed after 24-48 h. These kinetics indicated that the production of IL-10 by human monocytes was relatively late as compared to the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, tumor necrosis factor alpha (TNF alpha), and granulocyte colony-stimulating factor (G-CSF), which were all secreted at high levels 4-8 h after activation. The production of IL-10 by LPS activated monocytes was, similar to that of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF, inhibited by IL-4. Furthermore we demonstrate here that IL-10, added to monocytes, activated by interferon gamma (IFN-gamma), LPS, or combinations of LPS and IFN-gamma at the onset of the cultures, strongly inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF at the transcriptional level. Viral-IL-10, which has similar biological activities on human cells, also inhibited the production of TNF alpha and GM-CSF by monocytes following LPS activation. Activation of monocytes by LPS in the presence of neutralizing anti-IL-10 monoclonal antibodies resulted in the production of higher amounts of cytokines relative to LPS treatment alone, indicating that endogenously produced IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF. In addition, IL-10 had autoregulatory effects since it strongly inhibited IL-10 mRNA synthesis in LPS activated monocytes. Furthermore, endogenously produced IL-10 was found to be responsible for the reduction in class II major histocompatibility complex (MHC) expression following activation of monocytes with LPS. Taken together our results indicate that IL-10 has important regulatory effects on immunological and inflammatory responses because of its capacity to downregulate class II MHC expression and to inhibit the production of proinflammatory cytokines by monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-10 inhibits production of pro-inflammatory cytokines, such as TNF127.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512 · cited 1×
“6% formaldehyde, transferred to Nytran nylon membranes (Schleicher & Schuell, Keene, NH) and hybridized with probes, labeled to high specific activity (>10 s cpm//~g) by the hexamer labeling technique (23).”
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460 · cited 1×
“Total ILNA was isolated from 20 x 106 monocytes by the guanidinium thioeyanateCsC1 procedure (22).”
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975 · cited 1×
“the activation and function of cells of the immune system but also those of endothelial cells, keratinocytes and hepatocytes (42-44), suggests that II.”
Malefyt, R. D. W., Haanen, J. B. A. G., Spits, H., Roncarolo, M., Velde, A. A. T., Figdor, C. G., Johnson, K., KASTELEIN, R. A., Yssel, H., & de Vries, J. E. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Self-citationIL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,732 · cited 2×
“-6 sense primer 5'-ATGAACTCCTTCTCCACAAGC-3' (nt 1 - 21), Ib6 anti sense primer 5'-CTACATTTGCCGAAGAGCCCTCAGGCTGGACTG-3' (nt 810 - 777) (17), Ib8 sense primer 5'-ATGACTTCCAAGCTGGCCGTG-3' (nt 1 - 21), I1-8 anti sense primer 5'-TTATGAATTCTCAGCCCTCTTCAAAAACTTCTC-Y (nt 302 - 269) (15), IL-10 sense primer 5'-ATGCCCCAAGCTGAGA…”
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559 · cited 2×
“The following oligonucleotides were used for Southern analysis of PCR products: IL-lot: 5'-CATGGGTGCTTATAAGTCATC-Y (nt 500-521) (16); IL-1/3: 5'-CGATCACTGAACTGCACGCTCCGGG-3' (nt 444 469) (16); Ib6: 5'GAGGTATACCTAGAGTACCTC-Y (nt 510 - 531) (17); IL-8: 5'-TAAAGACATACTCCAAACCTT-3' (nt 200 - 221) (15); IL-10: 5'-CAGGTGAAG…”
Cited by
Sorted by citations
Items 301–400 of 1,009
Suárez, A., Castro, P. G., Alonso‐Arias, R., Mozo, L., & Gutiérrez, C. (2003) · Transplantation · doi:10.1097/01.tp.0000055216.19866.9a · Cited by 231
c-Maf Regulates IL-10 Expression during Th17 Polarization
Xu, J., Yang, Y., Qiu, G., Lal, G., Wu, Z., Levy, D. E., Ochando, J., Bromberg, J. S., & Ding, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900123 · Cited by 230
Pisa, P., Halapi, E. C., Pisa, E. K., Gerdin, E., Hising, C., Bucht, A., Gerdin, B., & Kiessling, R. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7708 · Cited by 231
Benjamin, D., Knobloch, T. J., & Dayton, M. (1992) · Blood · doi:10.1182/blood.v80.5.1289.1289 · Cited by 231
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X., Catino, J. J., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.579 · Cited by 230
A receptor for interleukin 10 is related to interferon receptors.
Ho, A. S., Liu, Y., Khan, T. A., Hsu, D., Bazán, J. F., & Moore, K. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11267 · Cited by 230
Interleukin-10: Biology, Role in Inflammation and Autoimmunity
Lalani, I., Bhol, K. C., & Ahmed, A. R. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63052-9 · Cited by 230
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G. T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R. E., Kern, P. A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90885.2008 · Cited by 229
Brandtzaeg, P., Osnes, L., Øvstebø, R., Joø, G. B., Westvik, Å.-B., & Kierulf, P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.51 · Cited by 229
Ozmen, L., Pericin, M., Hakimi, J., Chizzonite, R., Wysocka, M., Trinchieri, G., Gately, M. K., & Garotta, G. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.907 · Cited by 229
Byrne, A. M., & Reen, D. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1968 · Cited by 228
TLR-dependent cross talk between human Kupffer cells and NK cells
Tu, Z., Bozorgzadeh, A., Pierce, R. H., Kurtis, J. D., Crispe, I. N., & Orloff, M. S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072195 · Cited by 242
Michlewska, S., Dransfield, I., Megson, I. L., & Rossi, A. G. (2008) · The FASEB Journal · doi:10.1096/fj.08-121228 · Cited by 239
Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens
Cyktor, J. C., & Turner, J. (2011) · Infection and Immunity · doi:10.1128/iai.00047-11 · Cited by 227
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis
Laethem, J. V., Marchant, A., Delvaux, A., Goldman, M., Robberecht, P., Velu, T., & Deviere, J. M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90158-2 · Cited by 225
van Deuren, M., van der Ven‐Jongekrijg, J., Bartelink, A. K. M., van Dalen, R., Sauerwein, R. W., & van der Meer, J. W. M. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.2.433 · Cited by 225
Shaping of monocyte and macrophage function by adenosine receptors
Haskó, G., Pacher, P., Deitch, E. A., & Vizi, E. S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.003 · Cited by 232
Szabó, G., Mandrekar, P., Girouard, L., & Catalano, D. E. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05269.x · Cited by 224
Induction of hapten-specific tolerance by interleukin 10 in vivo.
Enk, A., Saloga, J., Becker, D., Mohamadzadeh, M., & Knop, J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1397 · Cited by 222
Molecular aspects of T – and B-cell function in uremia
Girndt, M., Sester, M., Sester, U., Kaul, H., & Kohler, H. J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780206.x · Cited by 223
Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐4
Cunha, F. Q., Poole, S., Lorenzetti, B. B., Veiga, F. H., & Ferreira, S. H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702266 · Cited by 226
Interleukin‐4 and Interferon‐γ: The Quintessence of a Mutual Antagonistic Relationship
Paludan (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00435.x · Cited by 223
van der Veek, P. P. J., van den Berg, M., de Kroon, Y. E., Verspaget, H. W., & Masclee, A. A. M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00257.x · Cited by 217
Genetic Polymorphisms in Sepsis and Septic Shock
Holmes, C. L., Russell, J. A., & Walley, K. R. (2003) · CHEST Journal · doi:10.1378/chest.124.3.1103 · Cited by 218
Gomes, B. P. F. D. A., & Herrera, D. R. (2018) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2018.vol32.0069 · Cited by 230
Dayan, V., Yannarelli, G., Billia, F., Filomeno, P., Wang, X.-H., Davies, J. E., & Keating, A. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0221-9 · Cited by 249
Anti-inflammatory effects of carvacrol: Evidence for a key role of interleukin-10
Lima, M. D. S., Quintans‐Júnior, L. J., de Santana, W. A., Kaneto, C. M., Soares, M. B. P., & Villarreal, C. F. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.040 · Cited by 219
Neidhardt, R., Keel, M. J. B., Steckholzer, U., Safret, A., Ungethuem, U., Trentz, O., & Ertel, W. (1997) · doi:10.1097/00005373-199705000-00017 · Cited by 217
A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis
Wilson, E. H., Wille-Reece, U., Dzierszinski, F. S., & Hunter, C. A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.018 · Cited by 218
Eskdale, J., Keijsers, V., Huizinga, T. W. J., & Gallagher, G. E. (1999) · Genes and Immunity · doi:10.1038/sj.gene.6363656 · Cited by 217
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression
Gong, J., Zhang, M., Modlin, R. L., Linsley, P. S., Iyer, D., Lin, Y.-P., & Barnes, P. F. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.913-918.1996 · Cited by 214
Insulin Attenuates the Systemic Inflammatory Response in Endotoxemic Rats
Jeschke, M. G., Klein, D., Bolder, U., & Einspanier, R. (2004) · Endocrinology · doi:10.1210/en.2004-0592 · Cited by 220
Nikolaus, S., Bauditz, J., Gionchetti, P., Witt, C. J., Lochs, H. H., & Schreiber, S. (1998) · Gut · doi:10.1136/gut.42.4.470 · Cited by 214
Beebe, A. M., Cua, D. J., & Malefyt, R. D. W. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00025-4 · Cited by 215
Chiaramonte, M. G., Schopf, L. R., Neben, T. Y., Cheever, A. W., Donaldson, D. D., & Wynn, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.920 · Cited by 216
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis
Fenton, M. J., Vermeulen, M. W., Kim, S., Burdick, M., Strieter, R. M., & Kornfeld, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5149-5156.1997 · Cited by 209
Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice
Beamer, G., Flaherty, D. K., Assogba, B. D., Stromberg, P. C., Juarrero, M. G., Malefyt, R. D. W., Vesosky, B., & Turner, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5545 · Cited by 216
Mayer-Barber, K. D., & Yan, B. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 210
Schwenk, W., Jacobi, C., Mansmann, U., Böhm, B., & Müller, J. M. (2000) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050002 · Cited by 212
Interleukin-10 inhibits interleukin-8 production in human neutrophils
Wang, P., Wu, P., Anthes, J., Siegel, M. I., Egan, R., & Billah, M. (1994) · Blood · doi:10.1182/blood.v83.9.2678.2678 · Cited by 213
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro
Morikawa, K., Watabe, H., Araake, M., & Morikawa, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1366 · Cited by 211
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb
Silvestre, J.-S., Mallat, Z., Duriez, M., Tamarat, R., Bureau, M. F., Scherman, D., Duverger, N., Branellec, D., Tedgui, A., & Levy, B. I. (2000) · Circulation Research · doi:10.1161/01.res.87.6.448 · Cited by 210
Wound healing effect of electrospun silk fibroin nanomatrix in burn-model
Ju, H. W., Lee, O. J., Lee, J. M., Moon, B. M., Park, H. J., Park, Y. R., Lee, M. C., Kim, S. H., Chao, J. R., Ki, C. S., et al. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.12.055 · Cited by 209
Tuttolomondo, A., Pecoraro, R., & Pinto, A. V. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s67655 · Cited by 208
Ohgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 216
“It acts by inhibiting the production of pro-inflammatory cytokines such as TNFα and IL-6 (de Waal Malefyt et al., 1991).”
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
von der Thüsen, J. H., Kuiper, J., van Berkel, T. J. C., & Biessen, E. A. L. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.5 · Cited by 212
Lung preservation: The importance of endothelial and alveolar type II cell integrity
Novick, R. J., Gehman, K. E., Ali, I. S., & Lee, J. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00333-5 · Cited by 207
TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a
Nyati, K. K., Masuda, K., Zaman, M. M.-U., Dubey, P. K., Millrine, D., Chalise, J. P., Higa, M., Li, S., Standley, D. M., Saito, K., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx064 · Cited by 190
“(G) Diagram of the region of the pGL3 vector that encodes the Arid5a 3′ UTR (1–3532), Arid5a 3′ UTR (1-800), or Arid5a 3′ UTR (800–3532).”
Innate Immune Responses of Human Neonatal Cells to Bacteria from the Normal Gastrointestinal Flora
Karlsson, H., Hessle, C. C., & Rudin, A. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6688-6696.2002 · Cited by 206
Csóka, B., Nemeth, Z. H., Virág, L., Gergely, P., Leibovich, S. J., Pacher, P., Sun, C.-X., Blackburn, M. R., Vizi, E. S., Deitch, E. A., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065870 · Cited by 207
Pro- and anti-inflammatory cytokines during acute severe pancreatitis
Brivet, F. G., Émilie, D., & Galanaud, P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199904000-00029 · Cited by 205
Differential Regulation of Interleukin-10 (IL-10) and IL-12 by Glucocorticoids In Vitro
Visser, J. T. J., van Boxel-Dezaire, A. H. H., Methorst, D., Brunt, T. M., de Kloet, E. R., & Nagelkerken, L. M. (1998) · Blood · doi:10.1182/blood.v91.11.4255 · Cited by 205
Joyce, D. A., Gibbons, D. L., Green, P. A., Steer, J. H., Feldmann, M., & Brennan, F. M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241119 · Cited by 205
Serum cytokines and growth factor levels in Japanese patients with psoriasis
Takahashi, H., Tsuji, H., Hashimoto, Y., Ishida‐Yamamoto, A., & Iizuka, H. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03704.x · Cited by 204
Chitosan-based copper nanocomposite accelerates healing in excision wound model in rats
Gopal, A., Kant, V., Gopalakrishnan, A., Tandan, S. K., & Kumar, D. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.033 · Cited by 217
Ye, S.-M., & Johnson, R. W. (2001) · Neuroimmunomodulation · doi:10.1159/000049025 · Cited by 203
Cytokine localization in multiple sclerosis lesions
Brosnan, C. F., Cannella, B., Battistini, L., & Raine, C. S. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s16 · Cited by 202
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection.
Zhang, M., Gong, J., Iyer, D., Jones, B. E., Modlin, R. L., & Barnes, P. F. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117611 · Cited by 202
Whalen, J. D., Lechman, E. L., Carlos, C. A., Weiss, K. R., Kovesdi, I., Glorioso, J. C., Robbins, P. D., & Evans, C. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3625 · Cited by 200
Tu, W., Chen, S. F., Sharp, M., Dekker, C., Manganello, A., Tongson, E. C., Maecker, H. T., Holmes, T. H., Wang, Z., Kemble, G. W., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3260 · Cited by 201
Wu, M.-H., Pan, T., Wu, Y., Chang, S.-J., Chang, M.-S., & Hu, C.-Y. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.09.003 · Cited by 202
Postischemic Gene Transfer of Interleukin-10 Protects Against Both Focal and Global Brain Ischemia
Ooboshi, H., Ibayashi, S., Shichita, T., Kumai, Y., Takada, J., Ago, T., Arakawa, S., Sugimori, H., Kamouchi, M., Kitazono, T., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155622.68580.dc · Cited by 201
Nair, S., Ramaswamy, P. A., Ghosh, S., Joshi, D., Pathak, N., Siddiqui, I., Sharma, P., Hasnain, S. E., Mande, S. C., & Mukhopadhyay, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901367 · Cited by 198
Delgado, M., Muñoz‐Elías, E. J., Gomariz, R. P., & Ganea, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1707 · Cited by 197
THE ACUTE INFLAMMATORY RESPONSE IN DIVERSE SHOCK STATES
Chow, C. C., Clermont, G., Kumar, R., Lagoa, C., Tawadrous, Z., Gallo, D. J., Betten, B., Bartels, J. D., Constantine, G. M., Fink, M. P., et al. (2005) · Shock · doi:10.1097/01.shk.0000168526.97716.f3 · Cited by 197
Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1.
Mulligan, M. S., Vaporciyan, A. A., Miyasaka, M., Tamatani, T., & Ward, P. A. (1993) · PubMed Central · Cited by 200
Kaji, R., Kiyoshima‐Shibata, J., Nagaoka, M., Nanno, M., & Shida, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901569 · Cited by 199
Functions and regulation of T cell-derived interleukin-10
Neumann, C., Scheffold, A., & Rutz, S. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101344 · Cited by 211
BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages
Wessells, J., Baer, M., Young, H. A., Claudio, E., Brown, K., Siebenlist, U. K., & Johnson, P. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404246200 · Cited by 195
Essential Role for IL-10 in Resistance to Lipopolysaccharide-Induced Preterm Labor in Mice
Robertson, S. A., Skinner, R. J., & Care, A. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4888 · Cited by 195
Ishida, H., Hastings, R., Kearney, J. F., & Howard, M. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.5.1213 · Cited by 196
Role of interleukin-10 in breast cancer
Hamidullah, Changkija, B., & Konwar, R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1855-x · Cited by 199
“IL-10 prohibits human monocytes from producing IL-1a, IL-1b, IL-6, IL-8, TNF-a, and G-CSF [42].”
BackgroundImprinted SARS-CoV-2-Specific Memory Lymphocytes Define Hybrid Immunity
Rodda, L. B., Morawski, P. A., Pruner, K. B., Fahning, M. L., Howard, C. A., Franko, N., Logue, J. K., Eggenberger, J., Stokes, C., Golez, I., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.018 · Cited by 200
“IL-10 can inhibit TNF-a and other pro-inflammatory cytokines in order to regulate inflammatory responses to infection (O’Garra and Vieira, 2007; De Waal Malefyt et al., 1991; Gazzinelli et al., 1996; Hunter et al., 1997).”
BackgroundA Novel Role for TGF-β and IL-10 in the Induction of Immune Privilege
D'Orazio, T. J., & Niederkorn, J. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2089 · Cited by 259
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis
Howell, M. D., Novak, N., Bieber, T., Pastore, S., Girolomoni, G., Boguniewicz, M., Streib, J., Wong, C., Gallo, R. L., & Leung, D. Y. M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23776.x · Cited by 193
Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape
Salazar‐Onfray, F., López, M. N., & Mendoza‐Naranjo, A. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.015 · Cited by 216
Immunomodulatory Activity of VEGF in Cancer
Lapeyre-Prost, A., Terme, M., Pernot, S., Pointet, A., Voron, T., Tartour, É., & Taı̈eb, J. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.007 · Cited by 203
Ball, J. K., Curran, R., Irving, W. L., & Dearden, A. A. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199911)59:3 · Cited by 34
Anti‐inflammatory cytokines in asthma and allergy: interleukin‐10, interleukin‐12, interferon‐γ
Chung, K. F. (2001) · Mediators of Inflammation · doi:10.1080/09629350120054518 · Cited by 195
Yee, L. J. (2001) · Hepatology · doi:10.1053/jhep.2001.22347 · Cited by 192
Aetiology and pathogenesis of hidradenitis suppurativa
Wolk, K., Join‐Lambert, O., & Sabat, R. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19556 · Cited by 206
Attenuation of Astroglial Reactivity by Interleukin-10
Balasingam, V., & Yong, V. W. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-09-02945.1996 · Cited by 186
Human cytokine responses to cardiac transplantation and coronary artery bypass grafting
Wan, S., Marchant, A., DeSmet, J.-M., Antoine, M., Zhang, H., Vachiéry, J., Goldman, M., Vincent, J., & LeClerc, J.-L. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70458-0 · Cited by 190
Kok, M. R., Yamano, S., Lodde, B. M., Wang, J., Couwenhoven, R. I., Yakar, S., Voutetakis, A., LeRoith, D., Schmidt, M., Afione, S. A., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322542257 · Cited by 190
Ledeboer, A., Brevé, J. J. P., Wierinckx, A., Jagt, S. V. D., Bristow, A. F., Leysen, J. E., Tilders, F. J. H., & van Dam, A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02200.x · Cited by 190
Kinetics of Allergen-Induced Airway Eosinophilic Cytokine Production and Airway Inflammation
GAUVREAU, G. M., WATSON, R. M., & O’Byrne, P. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9809130 · Cited by 190
Marin, D. E., Țăranu, I., Bunaciu, R. P., Pascale, F., Tudor, D. S., Avram, N., Sarca, M., Cureu, I., CRISTE, R. D., Suta, V., et al. (2002) · Journal of Animal Science · doi:10.2527/2002.8051250x · Cited by 190
IL-19 Induced Th2 Cytokines and Was Up-Regulated in Asthma Patients
Liao, S.-C., Cheng, Y.-C., Wang, Y.-C., Wang, C.-W., Yang, S.-M., Yu, C., Shieh, C.-C. K., Cheng, K.-C., Lee, M.-F., Chiang, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6712 · Cited by 189
Hernández, C., Segura, R., Fonollosa, A., Carrasco, E., Francisco, G., & Simó, R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01538.x · Cited by 189
Han, W., Lou, Y., Junmin, T. A. N. G., Zhang, Y., Chen, Y., Li, Y., Gu, W., Huang, J., Gui, L., Tang, Y., et al. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570127 · Cited by 189
Nockher, W. A., & Scherberich, J. E. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2782-2790.1998 · Cited by 188
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.
van der Poll, T., Jansen, J., Levi, M. M., Cate, H. T., ten Cate, J. W., & van Deventer, S. J. H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1985 · Cited by 188
Role of IL-10 in the Resolution of Airway Inflammation
Ogawa, Y., Duru, E. A., & Ameredes, B. T. (2008) · Current Molecular Medicine · doi:10.2174/156652408785160907 · Cited by 185
Reitamo, S., Remitz, A., Tamai, K., & Uitto, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117618 · Cited by 185
Vecchiarelli, A., Retini, C., Monari, C., Tascini, C., Bistoni, F., & Kozel, T. R. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2846-2849.1996 · Cited by 185
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis
Quraishi, S. A., PASCALE, G. D., Needleman, J. S., Nakazawa, H., Kaneki, M., Bajwa, E. K., Camargo, C. A., & Bhan, I. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001148 · Cited by 183
Katsiari, C. G., Liossis, S. C., & Sfikakis, P. P. (2009) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.11.002 · Cited by 182
Ozmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B., & Garotta, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250103 · Cited by 184
van der Poll, T., Malefyt, R. D. W., Coyle, S. M., & Lowry, S. F. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.1.118 · Cited by 182
Graves, D. T., Delima, A. J., Assuma, R., Amar, S., Oates, T. W., & Cochran, D. L. (1998) · Journal of Periodontology · doi:10.1902/jop.1998.69.12.1419 · Cited by 182
Metadata
- Authors
- de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E.
- Affiliations
- Department of Human Immunology, DNAX Research Institute, Palo Alto, California 94304.
- ORCID
- Figdor, C G
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-11-01
- Volume
- 174
- Issue
- 5
- Pages
- 1209-1220
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2119001
- OpenAlex
- W2191654227
- Cited by
- 3,762
- References
- 41
- Citations by year
- 2026: 25 · 2025: 41 · 2024: 45 · 2023: 60 · 2022: 58 · 2021: 68 · 2020: 67 · 2019: 80 · 2018: 69 · 2017: 71 · 2016: 97 · 2015: 98 · 2014: 132 · 2013: 107 · 2012: 122
- FWCI
- 39.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- IL-10, monocytes, cytokine synthesis inhibition, lipopolysaccharide stimulation, interferon-gamma, autoregulation, cytokine gene expression, MHC class II expression, viral IL-10, TNF-α, GM-CSF, granulocyte colony-stimulating factor, interleukin-6, interleukin-8
- MeSH terms
- Histocompatibility Antigens Class II, Base Sequence, Cells, Cultured, Homeostasis, Humans, Interferon-gamma, Interleukin-1, Lipopolysaccharides, Molecular Sequence Data, Monocytes, RNA, Messenger, Transcription, Genetic, Interleukin-4, Interleukin-6, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Transforming Growth Factor beta, Interleukin-10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review